Cipla reported INR8B in Cash and Equivalent for its fiscal quarter ending in March of 2025.


Cash And Equivalent Change Date
Cipla INR 8B 1.22B Mar/2025
Dr.Reddys Laboratories INR 9B 5.65B Jun/2025
Life Technologies USD 17.22M 6.16M Jun/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 95.37B 56.27B Mar/2025